Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium ferulate for mild cognitive impairment
ChiCTR2300070778Phase 4Not yet recruiting
- Sponsor
- 71st Group Army Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Mild Cognitive Impairment (MCI) comparing Sodium ferulate arm with Placebo arm (2 arms). Primary endpoints: Montreal Cognitive Assessment (MoCA), Alzheimer’s Disease Assessment Scale-Cognitive Section (ADAS-cog) and 5 more. Planned start May 2023; status: not yet recruiting.
02
Drugs
sodium ferulate
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on ChiCTR2300070778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070778.